An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers (original) (raw)
- Experimental Oncology
- Published: 01 June 1990
British Journal of Cancer volume 61, pages 821–827 (1990)Cite this article
- 246 Accesses
- 102 Citations
- Metrics details
Abstract
Prognostic information is essential for the evaluation, judgement and optimal treatment of patients with squamous cell cancers (SCCs) of the upper aerodigestive tract. Using immunohistochemical and flow cytometric techniques, we have studied the significance of cellular expression of the Ki-67 antigen, epidermal growth factor receptor (EGFR), the transferrin receptor (TFR) and DNA ploidy status in a prospective analysis of patients with SCCs of the head and neck region. All 42 fresh tumour samples (five well differentiated; 28 moderately differentiated; nine poorly differentiated) expressed both EGFR and TFR to varying degrees. Receptor expression was most marked on the peripheral invading margin of cancer cell islands although staining was also demonstrated in a random fashion within cellular islands and consistently along the basal cell layer of overlying stratified squamous epithelium. The percentage of cancer cells that reacted with the Ki-67 monoclonal antibody was assessed as low (less than 10%) in 15 samples (35.8%), intermediate (10-30%) in 19 samples (45.2%) and high (greater than 30%) in eight samples (19.0%). Eleven of 15 samples (73%) with a low percentage reactivity were DNA diploid, whereas seven of eight samples (87.5%) with a high percentage reactivity were DNA aneuploid. Poorly differentiated SCCs were significantly more often aneuploid than were either moderately or well differentiated tumours. Our results suggest that EGFR and TFR are widely distributed on SCCs, especially on proliferating cells at the invading tumour margin. In addition, there is a close spatial correlation between cells expressing EGFR, TFR and those expressing the Ki-67 antigen. Tumours in which the staining intensity for both EGFR and TFR was intense invariably expressed the Ki-67 antigen in a high proportion of cells. Further patient follow-up will be important in determining whether intense EGFR and TFR staining, combined with a high percentage reactivity with Ki-67 antibody and DNA aneuploidy, will ultimately define a subset of head and neck cancer patients with a poor clinical outcome.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Queensland Institute of Medical Research, Royal Brisbane Hospital, Australia
JH Kearsley
Authors
- JH Kearsley
You can also search for this author inPubMed Google Scholar - KL Furlong
You can also search for this author inPubMed Google Scholar - RA Cooke
You can also search for this author inPubMed Google Scholar - MJ Waters
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Kearsley, J., Furlong, K., Cooke, R. et al. An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers.Br J Cancer 61, 821–827 (1990). https://doi.org/10.1038/bjc.1990.184
- Issue Date: 01 June 1990
- DOI: https://doi.org/10.1038/bjc.1990.184